Researchers have been excited about the medication , a groundbreaking dual treatment showing promising outcomes in early trials for weight management. It acts by impacting both pathways : GLP-1 and GIP, that , when engaged , help control cravings and boost metabolism . Initial findings indicate considerable size reduction and potential benefits for